Arsenic Trioxide; a Novel Therapeutic Agent for Prostate and Bladder Cancers
Publish place: Translational Research in Urology، Vol: 1، Issue: 1
Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 428
This Paper With 7 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
این Paper در بخشهای موضوعی زیر دسته بندی شده است:
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_TUMS-1-1_001
تاریخ نمایه سازی: 17 فروردین 1400
Abstract:
The effectiveness of arsenic trioxide (ATO) in treating blood diseases is one of the most striking developments in modern medicine. One of the most important benefits of ATO is the failure of bone marrow suppression. ATO has been proposed as a novel and effective medicine for cancer prevention and treatment with various functions including, induction of apoptosis through re-activating the Wnt inhibitor, growth inhibition via activation of phosphatidylinositol 3-kinase (PI3K)/AKT pathway, autophagy stimulation, induction of cell differentiation and angiogenesis via vascular endothelial growth factor A (VEGFA)-VEGFR2-PI3K/ extracellular signal‐regulated kinase (ERK) signaling path in cancer cells and ATO may be involved in the acetylation of histones and interfering with gene transcription. ATO can increase the synergistic effect in treatment and increased antitumor effects on prostate cancer cells via inhibiting Akt/mTOR signaling pathways, and so, ATO in combination with inhibiting glutathione synthesis can treat bladder cancer epithelial cells effectively.
Keywords:
Authors
Akram Mirzaei
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
Leila Zareian Baghdadabad
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
Mohammad Hatef Khorrami
Department of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
Seyed Mohammad Kazem Aghamir
Urology Research Center, Tehran University of Medical Sciences, Tehran, Iran
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :